Synaptic pathology in Alzheimer's disease: A review of ultrastructural studies

Neurobiology of Aging

Volumn 24, Issue 8, 2003, Pages 1029-1046

  Scheff, Stephen W ^a   Price, Douglas A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Aging; Alzheimer's disease; Association cortex; Cognitive ability; Neurodegeneration; Synapses; Synaptophysin

Indexed keywords

NEUROTRANSMITTER; SYNAPSIN; SYNAPTOPHYSIN;

ADAPTATION; AGE; AGED; AGING; ALZHEIMER DISEASE; ASSOCIATION CORTEX; AUTOPSY; BRAIN ATROPHY; BRAIN REGION; BRAIN TISSUE; CELL DENSITY; CELL LOSS; CINGULATE GYRUS; COGNITIVE DEFECT; CONFERENCE PAPER; DENDRITE; DENERVATION; DENSITOMETRY; DENTATE GYRUS; ELECTRON MICROSCOPY; FRONTAL CORTEX; FRONTAL LOBE; GRANULE CELL; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MICROSCOPY; MODEL; MORPHOLOGY; NEOCORTEX; NERVE CELL; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROBIOLOGY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROTRANSMISSION; NORADRENERGIC SYSTEM; PARIETAL LOBE; PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SYNAPSE; SYNAPTIC MEMBRANE; SYNAPTIC TRANSMISSION; TEMPORAL LOBE; ULTRASTRUCTURE;

EID: 0345276568     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2003.08.002     Document Type: Conference Paper

References (105)

1. Adams I. Comparison of synaptic changes in the precentral and postcentral cerebral cortex of aging humans: a quantitative ultrastructural study. Neurobiol. Aging. 8:1987;203-212.
2. Adams I. Plasticity of the synaptic contact zone following loss of synapses in the cerebral cortex of aging humans. Brain Res. 424:1987;343-351.
3. Alonso A., Zaidi T., Novak M., Grundke-Iqbal I., Iqbal K. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc. Natl. Acad. Sci. U.S.A. 98:2001;6923-6928.
4. Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allgem. Zeit. Psychiat. Psych-Gerich. Med. 64:1907;146-148.
5. Amaral DG, Insausti R. Hippocampal formation. In: Paxinos G, editor. The human nervous system. Sydney: Academic Press; 1990. p. 711-55.
6. Arendt T., Zvegintseva H.G., Leontovich T.A. Dendritic changes in the basal nucleus of Meynert and in the diagonal band nucleus in Alzheimer's disease - a quantitative Golgi investigation. Neuroscience. 19:1986;1265-1278.
7. Arnold S.E., Hyman B.T., Flory J., Damasio A.R., Van Hoesen G.W. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex. 1:1991;103-116.
8. Bertoni-Freddari C., Fattoretti P. Computer-assisted morphometry of synaptic plasticity during aging and dementia. Pathol. Res. Pract. 185:1989;799-802.
9. Bertoni-Freddari C., Fattoretti P., Casoli T., Meier-Ruge W., Ulrich J. Morphological adaptive response of the synaptic junctional zones in the human dentate gyrus during aging and Alzheimer's disease. Brain Res. 517:1990;69-75.
10. Bertoni-Freddari C., Meier-Ruge W., Ulrich J. Quantitative morphology of synaptic plasticity in the aging brain. Scanning Microsc. 2:1988;1027-1034.
11. Blessed G., Tomlinson B., Roth M. The association between quantitative measures of dementia and of senile changes in cerebral grey matter of elderly subjects. Br. J. Psychiatry. 114:1968;797-811.
12. Bobinski M., Wegiel J., Wisniewski H.M., Tarnawski M., Bobinski M., Reisberg B.et al. Neurofibrillary pathology - correlation with hippocampal formation atrophy in Alzheimer disease. Neurobiol. Aging. 17:1996;909-919.
13. Bowen D.M., Neary D. Cerebral biopsy in the study of Alzheimer's disease. Bull. Clin. Neurosci. 50:1985;44-48.
14. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
15. Braak H., Braak E. The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci. Res. 15:1992;6-31.
16. Cabalka L.M., Hyman B.T., Goodlett C.R., Ritchie T.C., Van Hoesen G.W. Alteration in the pattern of nerve terminal protein immunoreactivity in the perforant pathway in Alzheimer's disease and in rats after entorhinal lesions. Neurobiol. Aging. 13:1992;283-291.
17. Calverley RKS, Jones DG. Determination of numerical density of perforated and nonperforated synapses. In: Conn PM, editor. Quantitative and qualitative microscopy, vol. 3. New York: Academic Press; 1990. p. 155-72.
18. Cambon K., Davies H.A., Stewart M.G. Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice. Neuroscience. 97:2000;685-692.
19. Cragg B.G. The density of synapses and neurons in normal, mentally defective and aging human brains. Brain. 98:1975;81-90.
20. Cummings B.J., Cotman C.W. Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet. 346:1995;1524-1528.
21. Davies C.A., Mann D.M.A., Sumpter P.W., Yates P.O. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J. Neurol. Sci. 78:1987;151-164.
22. DeKosky S.T., Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27:1990;457-464.
23. DeKosky S.T., Scheff S.W., Markesbery W.R. Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease. Neurology. 35:1985;1425-1431.
24. Finger S. Origins of neuroscience: a history of explorations into brain function. New York: Oxford University Press; 1994.
25. Francis PT, Cross AJ, Bowen DM. Neurotransmitters and neuropeptides. In: Terry R, Katzman R, Bick KL, editors. Alzheimer disease. New York: Raven Press; 1994. p. 247-61.
26. Geddes J., Anderson K., Cotman C. Senile plaques as aberrant sprout-stimulating structures. Exp. Neurol. 94:1986;767-776.
27. Geddes J.W., Monaghan D.T., Cotman C.W., Lott I.T., Kim R.C., Chui H.C. Plasticity of hippocampal circuitry in Alzheimer's disease. Science. 230:1985;1179-1181.
28. Gibson P.H. EM study of the numbers of cortical synapses in the brains of aging people and people with Alzheimer-type dementia. Acta Neuropathol. 62:1983;127-133.
29. Gomez-Isla T., Price J.L., McKeel D.W., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16:1996;4491-4500.
30. Goto S., Hirano A. Neuronal inputs to hippocampal formation in Alzheimer's disease and in parkinsonism-dementia complex on Guam. Acta Neuropathol. 79:1990;545-550.
31. Gray E. Axo-somatic and axo-dendritic synapses of the cerebral cortex: an electron microscopic study. J. Anat. 93:1959;420-432.
32. Hamos J., DeGennaro L., Drachman D. Synaptic loss in Alzheimer's disease and other dementias. Neurology. 39:1989;355-361.
33. Harbaugh R.E., Reeder T.M., Senter H.J., Knopman D.S., Baskin D.S., Pirozzolo F.et al. Intracerebroventricular bethanechol chloride infusion in Alzheimer's disease. Results of a collaborative double-blind study. J. Neurosurg. 71:1989;481-486.
34. Heinonen O., Soininen H., Sorvari H., Kosunen O., Paljarvi L., Koivisto E.et al. Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease. Neuroscience. 64:1995;375-384.
35. Hillman D.E., Chen S. Reciprocal relationship between size of postsynaptic densities and their number: constancy in contact area. Brain Res. 295:1984;325-343.
36. Hof P.R., Bussiere T., Gold G., Kovari E., Giannakopoulos P., Bouras C. et al. Stereologic evidence for persistence of viable neurons in layer II of the entorhinal cortex and the CA1 field in Alzheimer disease. J. Neuropathol. Exp. Neurol. 62:2003;55-67.
37. Hof P.R., Cox K., Morrison J.H. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease. I. Superior frontal and inferior temporal cortex. J. Comp. Neurol. 301:1990;44-54.
38. Hoff S.F., Scheff S.W., Kwan A.Y., Cotman C.W. A new type of lesion-induced synaptogenesis. I. Synaptic turnover in non-denervated zones of the dentate gyrus in young adult rats. Brain Res. 222:1981;1-13.
39. Honer W.G., Dickson D.W., Gleeson J., Davies P. Regional synaptic pathology in Alzheimer's disease. Neurobiol. Aging. 13:1992;375-382.
40. Hoog A., Gould V.E., Grimelius L., Franke W.W., Falkmer S., Cheifec G. Tissue fixation methods alter the immunohistochemical demonstrability of synaptophysin. Ultrastruc. Pathol. 12:1988;673-678.
41. Huttenlocher P.R. Synaptic density in human frontal cortex-developmental changes and effects of aging. Brain Res. 163:1979;195-205.
42. Hyman B., Van Hoesen G., Kromer L., Damasio A. Perforant pathway changes and memory impairment of Alzheimer's disease. Ann. Neurol. 20:1986;472-481.
43. Ihara Y. Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease. Brain Res. 459:1988;138-144.
44. Khachaturian Z.D. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1105.
45. Lippa C.F., Hamos J.E., Pulaski-Salo D., Degennaro L.J., Drachman D.A. Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses. Neurobiol. Aging. 13:1992;405-411.
46. Liu X., Erikson C., Brun A. Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration. Dementia. 7:1996;128-134.
47. Lovell M.A., Ehmann W.D., Butler S.M., Markesbery W.R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. 45:1995;1594-1601.
48. Lovell M.A., Xie C., Markesbery W.R. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging. 22:2001;187-194.
49. Markesbery W.R., Carney J.M. Oxidative alterations in Alzheimer's disease. Brain Pathol. 9:1999;133-146.
50. Markesbery W.R., Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging. 19:1998;33-36.
51. Martin E.M., Wilson R.S., Penn R.D., Fox J.H., Clasen R.A., Savoy S.M. Cortical biopsy results in Alzheimer's disease: correlation with cognitive deficits. Neurology. 37:1987;1201-1204.
52. Masliah E., Ellisman M., Carragher B., Mallory M., Young S., Hansen L.et al. Three dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer disease. J. Neuropathol. Exp. Neurol. 51:1992;404-414.
53. Masliah E., Mallory M., Alford M., DeTeresa R., Hansen L.A., McKeel D.W. Jr.et al. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology. 56:2001;127-129.
54. Masliah E., Mallory M., DeTeresa R., Alford M., Hansen L. Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies. Brain Res. 617:1993;258-266.
55. Masliah E., Mallory M., Hansen L., DeTeresa R., Alford M., Terry R. Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci. Lett. 174:1994;67-72.
56. Masliah E., Terry R., DeTeresa R., Hansen L. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci. Lett. 103:1989;234-239.
57. Masliah E., Terry R.D., Alford M., DeTeresa R. Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections. J. Histochem. Cytochem. 38:1990;837-844.
58. Masliah E., Terry R.D., Alford M., DeTeresa R., Hansen L.A. Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimer's disease. Am. J. Pathol. 138:1991;235-246.
59. Masliah E., Terry R.D., Mallory M., Alford M., Hansen L.A. Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. Am. J. Pathol. 137:1990;1293-1297.
60. Mayhew T., Gundersen H. If you assume, you can make an ass out of u and me: a decade of the disector for stereological counting of particles in a 3D space. J. Anat. 188:1996;1-15.
61. McKhann G., Drachman D., Folstein M., Katzman D. Clinical diagnosis of Alzheimer's disease. Neurology. 34:1984;939-944.
62. Morris J.C., Storandt M., McKeel S.W., Rubin E.H., Price J.L., Grant E.A.et al. Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology. 46:1996;707-719.
63. Morrison J.H., Hof P.R., Bouras C. An anatomic substrate for visual disconnection in Alzheimer's disease. Ann. N.Y. Acad. Sci. 640:1991;36-43.
64. Morsch R., Simon W., Coleman P.D. Neurons may live for decades with neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 58:1999;188-197.
65. Oorschot D. Are you using the neuronal densities, synaptic densities or neurochemical densities as your definitive data? There is a better way to go. Prog. Neurobiol. 44:1994;233-247.
66. Palay S.L. Synapses in the central nervous system. J. Biophys. Biochem. Cytol. 2(Suppl.):1956;193-202.
67. Palay S.L., Palade G. The fine structure of neurons. J. Biophys. Biochem. Cytol. 1:1955;69-88.
68. Paula-Barbosa M.M., Saraiva A., Tavares M.A., Borges M.M., Verwer R.W.H. Alzheimer's disease: maintenance of neuronal and synaptic densities in frontal cortical layers II and III. Acta Neurol. Scand. 74:1986;404-408.
69. Pearson R.C., Esiri M.M., Hiorns R.W., Wilcock G.K., Powell T.P. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 82:1985;4531-4534.
70. Perdahl E., Adolfsson R., Alafuzoff I., Albert K.A., Nestler E.J., Greengard P.et al. Synapsin I (protein I) in different brain regions in senile dementia of Alzheimer type and in multiinfarct dementia. J. Neural Transm. 60:1984;133-141.
71. Petit T.L., LeBoutillier J.C. Quantifying synaptic number and structure: effects of stain and post-mortem delay. Brain Res. 517:1990;269-275.
72. Price J.L., Morris J.C. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann. Neurol. 45:1999;358-368.
73. Probst A., Basler V., Bron B., Ulrich J. Neuritic plaques in senile dementia of Alzheimer type: a Golgi analysis in the hippocampal region. Brain Res. 268:1983;249-254.
74. Reisberg B., Ferris S.H., de Leon M.J., Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiatry. 139:1982;1136-1139.
75. Represa A., Duyckaerts C., Tremblay E., Hauw J.J., Ben-Ari Y. Is senile dementia of the Alzheimer type associated with hippocampal plasticity? Brain Res. 457:1988;355-359.
76. Rogers J., Morrison J.H. Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease. J. Neurosci. 5:1985;2801-2808.
77. Samuel W., Masliah E., Hill L.R., Butters N., Terry R. Hippocampal connectivity and Alzheimer's dementia: effects of synapse loss and tangle frequency in a two-component model. Neurology. 44:1994;2081-2088.
78. Scheff S.W., DeKosky S.T., Price D.A. Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol. Aging. 11:1990;29-37.
79. Scheff S.W., Price D.A. Synapse loss in the temporal lobe in Alzheimer's disease. Ann. Neurol. 33:1993;190-199.
80. Scheff S.W., Price D.A. Synaptic density in the inner molecular layer of the hippocampal dentate gyrus in Alzheimer disease. J. Neuropathol. Exp. Neurol. 57:1998;1146-1153.
81. Scheff S.W., Price D.A. Alzheimer's disease-related synapse loss in the cingulate cortex. J. Alzheimer Dis. 3:2001;495-505.
82. Scheff S.W., Price D.A., Sparks D.L. Quantitative assessment of possible age-related change in synaptic numbers in the human frontal cortex. Neurobiol. Aging. 22:2001;355-365.
83. Scheff S.W., Sparks D.L., Price D.A. Quantitative assessment of synaptic density in the entorhinal cortex in Alzheimer's disease. Ann. Neurol. 34:1993;356-361.
84. Scheff S.W., Sparks D.L., Price D.A. Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease. Dementia. 7:1996;213-220.
85. Scott S.A., DeKosky S.T., Scheff S.W. Volumetric atrophy of the amygdala in Alzheimer's disease: quantitative serial reconstruction. Neurology. 41:1991;351-356.
86. Scott S.A., DeKosky S.T., Sparks D.L., Knox C.A., Scheff S.W. Amygdala cell loss and atrophy in Alzheimer's disease. Ann. Neurol. 32:1992;555-563.
87. Simic G., Kostovic I., Winglad B., Bogdanovic N. Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease. J. Comp. Neurol. 379:1997;482-494.
88. Small D.H., Mok S.S., Bornstein J.C. Alzheimer's disease and Abeta toxicity: from top to bottom. Nat. Rev. Neurosci. 2:2001;595-598.
89. Sparks D.L. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Ann. N.Y. Acad. Sci. 826:1997;128-146.
90. Sparks D.L., Huaichen L., Scheff S.W., Coyne C.M., Hunsaker J.C. Temporal sequence of plaque formation in the cerebral cortex of non-demented individuals. J. Neuropathol. Exp. Neurol. 52:1993;135-142.
91. Sparks D.L., Hunsaker J.C., Scheff S.W., Kryscio R.J., Henson J.L., Markesbery W.R. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol. Aging. 11:1990;601-607.
92. Stamer K., Vogel R., Thies E., Mandelkow E., Mandelkow E.M. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 156:2002;1051-1063.
93. Sze C.I., Troncoso J.C., Kawas C., Mouton P., Price D.L., Martin L.J. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J. Neuropathol. Exp. Neurol. 56:1997;933-944.
94. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R.et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:1991;572-580.
95. Vogt B.A., Crino P.B., Vogt L.J. Reorganization of cingulate cortex in Alzheimer's disease: neuron loss, neuritic plaques, and muscarinic receptor binding. Cereb. Cortex. 2:1992;526-535.
96. Vogt B.A., Crino P.B., Volicer L. Laminar alterations in gamma-aminobutyric acidA, muscarinic, and beta adrenoceptors and neuron degeneration in cingulate cortex in Alzheimer's disease. J. Neurochem. 57:1991;282-290.
97. Vogt B.A., Pandya D.N. Cingulate cortex of the rhesus monkey. II. Cortical afferents. J. Comp. Neurol. 262:1987;271-289.
98. Vogt B.A., Pandya D.N., Rosene D.L. Cingulate cortex of the rhesus monkey. I. Cytoarchitecture and thalamic afferents. J. Comp. Neurol. 262:1987;256-270.
99. Vogt B.A., Van Hoesen G.W., Vogt L.J. Laminar distribution of neuron degeneration in posterior cingulate cortex in Alzheimer's disease. Acta Neuropathol. 80:1990;581-589.
100. Vogt B.A., Vogt L.J., Vrana K.E., Gioia L., Meadows R.S., Challa V.R.et al. Multivariate analysis of laminar patterns of neurodegeneration in posterior cingulate cortex in Alzheimer's disease. Exp. Neurol. 153:1998;8-22.
101. Wakabayaski K., Honer W.G., Masliah E. Synapse alterations in the hippocampal-entorhinal function in Alzheimer's disease with and without Lewy body disease. Brain Res. 667:1994;24-32.
102. West M.J. Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci. 22:1999;51-61.
103. West M.J., Coleman P.D., Flood D.G., Troncoso J.C. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet. 344:1994;769-772.
104. Yao P.J., Zhu M., Pyun E.I., Brooks A.I., Therianos S., Meyers V.E.et al. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol. Dis. 12:2003;97-109.
105. Zhan S.-S., Beyreuther K., Schmitt H.P. Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia. Dementia. 4:1993;66-74.